MetaCap

AnaptysBio Statistics

NASDAQ: ANABHealth CareBiotechnology: Pharmaceutical PreparationsUSD

46.63-0.77 (-1.62%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AnaptysBio by the numbers

AnaptysBio has a market capitalization of $1.39 billion based on 29.73M shares outstanding. Its trailing P/E ratio is 7.2, and its forward P/E is 8.7. The stock trades 4.6% below its 50-day average and 9.5% below its 200-day average.

Average daily trading volume is 496.92K shares, or about $23.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ANAB valuation vs. peer median

ANAB compared with the median of 8 peer companies
MetricANABPeer medianDifference
Market cap$1.39B$1.41B-2%
Avg. volume496.92K965.94K-49%

Peer median across 8 companies: NRIX, ADRX, TYRA, SRPT, KLRA, DMRA, RAPP, QURE.

Valuation

Price / sales (latest FY)
5.91

Price and trading

Previous close
47.40
Open
46.63
Day range
46.05 – 47.66
52-week range
26.01 – 72.36
52-week change
+76.58%
Beta
—
Volume
432.44K

Dividends and events

Annual dividend
None
Next earnings date
Sep 21, 2026

Additional statistics

Market Cap
1.39B
Pe
7.15
Forward Pe
8.66
Eps
6.52
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
72.36
Week52 Low
26.01
Avg Volume
496.92K
Shares Outstanding
29.73M
Ma50
48.88
Ma200
51.54
Earnings Date
Sep 21, 2026
Pct From52w High
-35.56%
Pct From52w Low
79.25%

Related